201 related articles for article (PubMed ID: 25213831)
1. Direct estradiol and diethylstilbestrol actions on early- versus late-stage prostate cancer cells.
Koong LY; Watson CS
Prostate; 2014 Dec; 74(16):1589-603. PubMed ID: 25213831
[TBL] [Abstract][Full Text] [Related]
2. Xenoestrogen interference with nongenomic signaling actions of physiological estrogens in endocrine cancer cells.
Watson CS; Koong L; Jeng YJ; Vinas R
Steroids; 2019 Feb; 142():84-93. PubMed ID: 30012504
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
[TBL] [Abstract][Full Text] [Related]
4. Divergent biological effects of estradiol and diethylstilbestrol in the prostate cancer cell line MOP.
Kalach JJ; Joly-Pharaboz MO; Chantepie J; Nicolas B; Descotes F; Mauduit C; Benahmed M; André J
J Steroid Biochem Mol Biol; 2005 Jul; 96(2):119-29. PubMed ID: 15950459
[TBL] [Abstract][Full Text] [Related]
5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
7. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
8. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
9. Toyocamycin induces apoptosis via the crosstalk between reactive oxygen species and p38/ERK MAPKs signaling pathway in human prostate cancer PC-3 cells.
Park SG; Kim SH; Kim KY; Yu SN; Choi HD; Kim YW; Nam HW; Seo YK; Ahn SC
Pharmacol Rep; 2017 Feb; 69(1):90-96. PubMed ID: 27912102
[TBL] [Abstract][Full Text] [Related]
10. Estrogens and ICI182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase.
Wong JK; Le HH; Zsarnovszky A; Belcher SM
J Neurosci; 2003 Jun; 23(12):4984-95. PubMed ID: 12832521
[TBL] [Abstract][Full Text] [Related]
11. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
12. Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds.
Li X; Zhang S; Safe S
J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):122-32. PubMed ID: 16413991
[TBL] [Abstract][Full Text] [Related]
13. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.
Bulayeva NN; Gametchu B; Watson CS
Steroids; 2004 Mar; 69(3):181-92. PubMed ID: 15072920
[TBL] [Abstract][Full Text] [Related]
15. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer.
Koike H; Ito K; Takezawa Y; Oyama T; Yamanaka H; Suzuki K
Br J Cancer; 2005 Apr; 92(8):1538-44. PubMed ID: 15846301
[TBL] [Abstract][Full Text] [Related]
17. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
18. Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis.
Permpongkosol S; Wang JD; Takahara S; Matsumiya K; Nonomura N; Nishimura K; Tsujimura A; Kongkanand A; Okuyama A
Int J Cancer; 2002 Mar; 98(2):167-72. PubMed ID: 11857403
[TBL] [Abstract][Full Text] [Related]
19. Time- and dose-related effects of estradiol and diethylstilbestrol on the morphology and function of the fetal rat testis in culture.
Lassurguère J; Livera G; Habert R; Jégou B
Toxicol Sci; 2003 May; 73(1):160-9. PubMed ID: 12657744
[TBL] [Abstract][Full Text] [Related]
20. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.
Xiao D; Singh SV
Cancer Res; 2002 Jul; 62(13):3615-9. PubMed ID: 12097262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
